244 related articles for article (PubMed ID: 9989102)
21. Risk of nodal metastases at laparoscopic pelvic lymphadenectomy using PSA, Gleason score, and clinical stage in men with localized prostate cancer.
Hoenig DM; Chi S; Porter C; Tackett L; Smith DS; Cohen SI; Stein BS
J Endourol; 1997 Aug; 11(4):263-5. PubMed ID: 9376845
[TBL] [Abstract][Full Text] [Related]
22. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
Lehrer S; Diamond EJ; Stagger S; Stone NN; Stock RG
Br J Cancer; 2002 Sep; 87(7):726-8. PubMed ID: 12232754
[TBL] [Abstract][Full Text] [Related]
23. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
24. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
Wong WW; Schild SE; Vora SA; Halyard MY
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
[TBL] [Abstract][Full Text] [Related]
25. Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.
Touijer K; Rabbani F; Otero JR; Secin FP; Eastham JA; Scardino PT; Guillonneau B
J Urol; 2007 Jul; 178(1):120-4. PubMed ID: 17499306
[TBL] [Abstract][Full Text] [Related]
26. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
Fair WR; Betancourt JE
Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
[TBL] [Abstract][Full Text] [Related]
27. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
[TBL] [Abstract][Full Text] [Related]
28. Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate.
Stone NN; Stock RG; Unger P
J Urol; 1995 Oct; 154(4):1392-6. PubMed ID: 7658545
[TBL] [Abstract][Full Text] [Related]
29. [Value and sequence of the biopsy of the seminal vesicles and laparoscopic pelvic lymphadenectomy in the staging of cancer of the prostate].
Blas Marín M; Allepuz Losa C; Rioja Sanz C; Mínguez J; Gonzalvo A; Plaza L; Rioja Sanz LA
Actas Urol Esp; 1997 Oct; 21(9):874-89. PubMed ID: 9471871
[TBL] [Abstract][Full Text] [Related]
30. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
[TBL] [Abstract][Full Text] [Related]
31. Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation.
Vargas CE; Galalae R; Demanes J; Harsolia A; Meldolesi E; Nürnberg N; Schour L; Martinez A
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1474-82. PubMed ID: 15964706
[TBL] [Abstract][Full Text] [Related]
32. [Laparoscopic pelvic lymph node dissection valuable in the staging of clinically localized prostate carcinoma].
Froeling FM; Witjes JA; Oosterhof GO
Ned Tijdschr Geneeskd; 1995 Mar; 139(12):618-22. PubMed ID: 7700405
[TBL] [Abstract][Full Text] [Related]
33. Predicting pelvic lymph node involvement in patients with localized prostate cancer.
Ekman P
Eur Urol; 1997; 32 Suppl 3():60-4. PubMed ID: 9267787
[TBL] [Abstract][Full Text] [Related]
34. Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era.
Nguyen PL; Chen MH; Hoffman KE; Katz MS; D'Amico AV
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):104-9. PubMed ID: 19286330
[TBL] [Abstract][Full Text] [Related]
35. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
[TBL] [Abstract][Full Text] [Related]
36. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
[TBL] [Abstract][Full Text] [Related]
37. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
Xylinas E; Drouin SJ; Comperat E; Vaessen C; Renard-Penna R; Misrai V; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Roupret M
BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
[TBL] [Abstract][Full Text] [Related]
38. Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases.
Bastide C; Brenot-Rossi I; Garcia S; Rossi D
Eur J Surg Oncol; 2009 Jul; 35(7):751-6. PubMed ID: 18538526
[TBL] [Abstract][Full Text] [Related]
39. A new minimally invasive open pelvic lymphadenectomy surgical technique for the staging of prostate cancer.
Brant LA; Brant WO; Brown MH; Seid DL; Allen RE
Urology; 1996 Mar; 47(3):416-21. PubMed ID: 8633413
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
